| Drug Name | (Vastarel ® (TRIMETAZIDINE |
|---|---|
| Drug Class |
Vasodilator
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Cardiology
|
| Risk |
Outcome of the Benefit-Risk Re-evaluation of Trimetazidine |
| Dear Healthcare provider letter DHPC |
|